FDA cites Cipla India plant after U.S. recall of asthma drug – FiercePharma Manufacturing

FDA cites Cipla India plant after U.S. recall of asthma drug
FiercePharma Manufacturing
In May, India's Cipla voluntarily pulled a lot of its levalbuterol from the U.S. market after the asthma inhalation drug failed a test for a degradant. Shortly after, FDA inspectors visited the plant in Indore where Cipla made the product and came away …

and more »